iShares Neuroscience and Healthcare ETF (NYSEARCA:IBRN) Short Interest Update

iShares Neuroscience and Healthcare ETF (NYSEARCA:IBRN) was the target of a large growth in short interest during the month of June. As of June 15th, there was short interest totaling 12,988 shares, a growth of 134.2% from the May 31st total of 5,546 shares. Approximately 8.7% of the shares of the company are short sold. Based on an average trading volume of 2,385 shares, the days-to-cover ratio is presently 5.4 days.

iShares Neuroscience and Healthcare ETF Stock Performance

IBRN traded up $0.49 during trading hours on Monday, reaching $38.72. The company’s stock had a trading volume of 3,661 shares, compared to its average volume of 1,991. The company’s 50-day moving average is $35.19 and its 200-day moving average is $33.31. iShares Neuroscience and Healthcare ETF has a 52 week low of $21.89 and a 52 week high of $38.84. The firm has a market cap of $5.81 million, a PE ratio of 15.61 and a beta of 0.77.

About iShares Neuroscience and Healthcare ETF

The iShares Neuroscience and Healthcare ETF (IBRN) is an exchange-traded fund that mostly invests in health care equity. The fund tracks a market cap-weighted index that provides global equity exposure to companies that are positioned to benefit from neuroscience advancements. The index may hold securities from large- to small-cap. IBRN was launched on Aug 24, 2022 and is managed by BlackRock.